RT Journal Article
SR Electronic
A1 Helwick, Caroline
T1 Milnacipran for the Treatment of Fatigue Associated with Fibromyalgia
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 4
SP 14
OP 14
DO 10.1177/155989771004009
UL http://mdc.sagepub.com/content/10/4/14.1.abstract
AB Milnacipran may be an effective treatment for the fatigue that is associated with fibromyalgia (FM). FM is a chronic disorder with symptoms, including musculoskeletal pain and allodynia, as well as debilitating fatigue. Milnacipran is a dual reuptake inhibitor of serotonin and norepinephrine that is used for the treatment of FM. This article discusses an evaluation the effect of milnacipran on fatigue in patients with FM (as determined by American College of Rheumatology criteria) in a pooled analysis of three Phase III trials.